Pure Global

Peru Decentralized HIV Care - Trial NCT05910268

Access comprehensive clinical trial information for NCT05910268 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Not yet recruiting. The study focuses on HIV. Target enrollment is 1450 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05910268
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05910268
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Peru Decentralized HIV Care
Innovations in Decentralizing HIV Services in Peru

Study Focus

HIV

NIATx + ECHO

Interventional

behavioral

Sponsor & Location

Yale University

New Haven,Bellavista, Peru,United States of America

Timeline & Enrollment

N/A

Jul 01, 2023

Jul 01, 2028

1450 participants

Primary Outcome

Percentage of diagnosed PWH in treatment in PHC within the district

Summary

The purpose of this study is to understand the processes by which HIV care is decentralized,
 an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of
 HIV services has not been evaluated using experimental designs and urban decentralization
 studies of HIV are uncommon, so this study will lend important insights for future
 decentralization efforts in Peru and other countries.

ICD-10 Classifications

Human immunodeficiency virus [HIV] disease
Human immunodeficiency virus [HIV] disease resulting in other conditions
HIV disease resulting in other viral infections
Unspecified human immunodeficiency virus [HIV] disease
Human immunodeficiency virus [HIV] disease resulting in other specified diseases

Data Source

ClinicalTrials.gov

NCT05910268

Non-Device Trial